Daaco, Irine Kate .

HRN: 15-39-50  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2022
OXACILLIN 500MG (VIAL)
08/09/2022
08/15/2022
IVT
Q6
21
CELLULITIS Left Leg And Thigh
08/09/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
08/09/2022
08/16/2022
TOPICAL
2%
Bid
Cellulitis
Waiting Final Action 
08/09/2022
OXACILLIN 500MG (VIAL)
08/09/2022
08/08/2022
IVT
160
Q6
CELLULITIS Left Leg And Thigh
Waiting Final Action 
08/09/2022
MUPIROCIN 2%, 15G (TUBE)
08/09/2022
08/16/2022
TOPICAL
2%
Bid
Cellulitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: